Clinical significance of anti-Ro antibodies in rheumatoid arthritis

Clinical Rheumatology

Volumn 27, Issue 4, 2008, Pages 517-519

  Schneeberger, Emilce ^a   Citera, Gustavo ^a   Heredia, Monica ^a   Cocco, José Maldonado ^a  

^a Instituto de Rehabilitación Psicofísica and Argentine Rheumatologic Foundation Dr Osvaldo García Morteo   (Argentina)

Author keywords

Anti Ro antibodies; Clinical significance; Disease severity; Rheumatoid arthritis

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; LA ANTIBODY; METHOTREXATE; RHEUMATOID FACTOR; RO ANTIBODY; SALAZOSULFAPYRIDINE;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DEMOGRAPHY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT RADIOGRAPHY; GENETIC ASSOCIATION; HAND RADIOGRAPHY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; SUBCUTANEOUS NODULE; THROMBOCYTOPENIA; XEROPHTHALMIA; XEROSTOMIA;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 40949162470     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0812-x     Document Type: Article

References (13)

1. Meyer O (1998) Anti-Ro (SS-A). Rev Rhum (Engl Ed) 65(2):85-88
2. Bouffard P, Laniel M-A, Boire G (1996) Anti-Ro (SSA) antibodies: clinical significance and biological relevance. J Rheumatol 23:1838-1841
3. Ben-Chetrit E (1993) The molecular basis of the SSA/Ro antigens and the clinical significance of their antibodies. Br J Rheumatol 32:396-402
4. Boire G, Ménard H-A, Gendron M, Lussier A, Myhal D (1993) Rheumatoid arthritis: Anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol 20:1654-1660
5. Skopouli FN, Andonopoulos AP, Moutsopoulos HM (1988) Clinical implication of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis. J Autoimmun 3:381-388
6. Smeenk R, Westgeest T, Swaak T (1985) Antinuclear antibody determination: The present state of diagnostic and clinical relevance. Scand J Rheumatol Suppl 56:78-92
7. Boire G, Ménard H-A (1988) Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis. J Rheumatol 15:391-394
8. Arnett FC, Edworthy SM, Bloch DA et al (1987) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
9. Panush RS, Edwards SM, Longley S, Webster E (1988) "Rhupus" syndrome. Arch Intern Med 148:1633-1636
10. Larsen A (1973) Radiological grading of rheumatoid arthritis: An interobserver study. Scand J Rheumatol 2:136-138
11. Tishler M, Moutsopoulos HM, Yaron M (1992) Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J Rheumatol 19:234-236
12. Tishler M, Golbrut B, Shoenfeld Y, Yaron M (1994) Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis a possible marker for gold induced side effects. J Rheumatol 21:1040-1042
13. Tishler M, Nyman J, Wahren M, Yaron M (1997) Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects. Rheumatol Int 17:133-135